Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel for Carotid Artery Stenting (PRECISE-MRI)
NCT02677545Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Dec 2016
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, triple-blind trial of ticagrelor in carotid artery stenosis (CAS), sponsored by University Hospital Basel. Primary endpoint: Proportion of patients with at least one new ischaemic brain lesion at 32 days. Started Dec 2016; status: completed.
02
Drugs
ticagrelor
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT02677545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677545.